211 related articles for article (PubMed ID: 30497801)
1. Primary anorectal melanoma: clinical, immunohistology and DNA analysis of 43 cases.
Dodds TJ; Wilmott JS; Jackett LA; Lo SN; Long GV; Thompson JF; Scolyer RA
Pathology; 2019 Jan; 51(1):39-45. PubMed ID: 30497801
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients.
Ren M; Dai B; Kong YY; Lv JJ; Cai X
Histopathology; 2018 Sep; 73(3):386-396. PubMed ID: 29637587
[TBL] [Abstract][Full Text] [Related]
3. Anorectal Melanoma - a Histopathological Case Report and a Review of the Literature.
Kobakova I; Stoyanov G; Popov H; Spasova-Nyagulova S; Stefanova N; Stoev L; Yanulova N
Folia Med (Plovdiv); 2018 Dec; 60(4):641-646. PubMed ID: 31188769
[TBL] [Abstract][Full Text] [Related]
4. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.
Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ
Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in primary anorectal melanoma: a clinicopathological study of 60 cases in China.
Ren M; Lu Y; Lv J; Shen X; Kong J; Dai B; Kong Y
Hum Pathol; 2018 Sep; 79():77-85. PubMed ID: 29763716
[TBL] [Abstract][Full Text] [Related]
6. Anorectal amelanotic melanoma.
Hillenbrand A; Barth TF; Henne-Bruns D; Formentini A
Colorectal Dis; 2008 Jul; 10(6):612-5. PubMed ID: 17944970
[TBL] [Abstract][Full Text] [Related]
7. Anal versus rectal melanoma: does site of origin predict outcome?
Bello DM; Smyth E; Perez D; Khan S; Temple LK; Ariyan CE; Weiser MR; Carvajal RD
Dis Colon Rectum; 2013 Feb; 56(2):150-7. PubMed ID: 23303142
[TBL] [Abstract][Full Text] [Related]
8. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.
Berghoff AS; Ricken G; Widhalm G; Rajky O; Dieckmann K; Birner P; Bartsch R; Höller C; Preusser M
Histopathology; 2015 Jan; 66(2):289-99. PubMed ID: 25314639
[TBL] [Abstract][Full Text] [Related]
9. [Anorectal melanomas. An immunohistochemical study of the cellular proliferation].
Díaz Iglesias JM; Fresno Forcelledo M; Pérez del Río MJ; Díaz Iglesias CJ; Campelo Mazé P; Herrero-Zapatero A
Rev Esp Enferm Dig; 1995 Jun; 87(6):481-2. PubMed ID: 7612376
[No Abstract] [Full Text] [Related]
10. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
11. Tumour diameter is a predictor of mesorectal and mesenteric lymph node metastases in anorectal melanoma.
Wang M; Zhang Z; Zhu J; Sheng W; Lian P; Liu F; Cai S; Xu Y
Colorectal Dis; 2013 Sep; 15(9):1086-92. PubMed ID: 23594152
[TBL] [Abstract][Full Text] [Related]
12. Anorectal malignant melanoma: retrospective analysis of management and outcome in a single Portuguese Institution.
Miguel I; Freire J; Passos MJ; Moreira A
Med Oncol; 2015 Jan; 32(1):445. PubMed ID: 25502089
[TBL] [Abstract][Full Text] [Related]
13. Primary amelanotic anorectal melanoma: an uncommon neoplasia with poor prognosis.
Khaled A; Hammami H; Fazaa B; Kourda N; Kamoun MR; Ben Jilany S; Zoghlami A
Pathologica; 2009 Jun; 101(3):126-9. PubMed ID: 19886548
[TBL] [Abstract][Full Text] [Related]
14. Surgical therapy for anorectal melanoma.
Bullard KM; Tuttle TM; Rothenberger DA; Madoff RD; Baxter NN; Finne CO; Spencer MP
J Am Coll Surg; 2003 Feb; 196(2):206-11. PubMed ID: 12595048
[TBL] [Abstract][Full Text] [Related]
15. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
16. Clinical Patterns of Melanoma in Asians: 11-Year Experience in a Tertiary Referral Center.
Chan KK; Chan RC; Ho RS; Chan JY
Ann Plast Surg; 2016 Feb; 77 Suppl 1():S6-S11. PubMed ID: 26808749
[TBL] [Abstract][Full Text] [Related]
17. Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlations.
Iacono D; Cinausero M; Gerratana L; Angione V; Scott CA; De Maglio G; Pizzolitto S; Di Loreto C; Puglisi F; Fasola G; Minisini AM
Melanoma Res; 2018 Dec; 28(6):547-554. PubMed ID: 29794562
[TBL] [Abstract][Full Text] [Related]
18. Anorectal melanoma: experience from a tertiary cancer care centre in South India.
Ranjith S; Muralee M; Sajeed A; Arun PM; Cherian K; Nair CK; Augustine P; Ahamed I
Ann R Coll Surg Engl; 2018 Mar; 100(3):185-189. PubMed ID: 29046101
[TBL] [Abstract][Full Text] [Related]
19. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
20. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.
Harter PN; Bernatz S; Scholz A; Zeiner PS; Zinke J; Kiyose M; Blasel S; Beschorner R; Senft C; Bender B; Ronellenfitsch MW; Wikman H; Glatzel M; Meinhardt M; Juratli TA; Steinbach JP; Plate KH; Wischhusen J; Weide B; Mittelbronn M
Oncotarget; 2015 Dec; 6(38):40836-49. PubMed ID: 26517811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
